GlassScriptPhysician profile
James Mark Gannon
NPI 1750359881
$15,400.46
in general payments reported to CMS, 2019-2025
7 companies · $2,179 in 2025
The $2,179 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,853 · 2020: $1,747 · 2021: $2,612 · 2022: $4,229 · 2023: $1,773 · 2024: $1,007 · 2025: $2,179.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,420 · Food and Beverage: $1,539.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,419.71 |
| Food and Beverage | $1,539.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $10,024.09 | 2019-2025 | |
| Gemini Medical LLC | $2,705.45 | 2020-2022 | |
| Foundation Medical, LLC | $1,819.91 | 2022-2025 | |
| Smith+Nephew, INC. | $354.05 | 2019 | |
| Stryker Corporation | $283.49 | 2020-2025 | Triathlon, Insignia, Mako |
| Medtronic, INC. | $202.52 | 2024 | Aquamantys(Tm) |
| Coopersurgical, INC. | $10.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Gannon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.